West Virginia HB4640 updates Schedule I controlled substances to include new synthetic drugs and substances.

West Virginia HB4640 amends Schedule I controlled substances to include a variety of new synthetic drugs and substances. These additions include synthetic opioids, benzodiazepines, cathinones, and other psychoactive compounds. The bill also specifies that crystalline polymorph psilocybin, if approved by the FDA and scheduled by the DEA, can be prescribed, distributed, and marketed. The updated Schedule I list aims to address the evolving landscape of synthetic drugs and their potential for abuse.

West Virginia HB4640 updates Schedule I controlled substances to include new synthetic drugs and substances.

West Virginia HB4640 amends Schedule I controlled substances to include a variety of new synthetic drugs and substances. These additions include synthetic opioids, benzodiazepines, cathinones, and other psychoactive compounds. The bill also specifies that crystalline polymorph psilocybin, if approved by the FDA and scheduled by the DEA, can be prescribed, distributed, and marketed. The updated Schedule I list aims to address the evolving landscape of synthetic drugs and their potential for abuse.